Osteopontin as a prognostic biomarker in head and neck cancer- a systematic review and meta-analysis
{{output}}
Background: Osteopontin (OPN) is linked to cancer progression, metastasis, and treatment resistance in head and neck cancer (HNC). This meta-analysis evaluated OPN as a prognostic biomarker in HNC. ... ...
